Funding opportunities
Open and upcoming programs from Canadian funders and US federal grants (Grants.gov). Deadlines first, then rolling intakes.
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
Food and Drug Administration · Deadline not published
The purpose of this FOA is to develop and maintain Rapid Response Teams (RRTs) to facilitate long-term improvements and innovation to the national integrated food safety system by unifying and coordinating federal/state/local human and animal food (HAF) emergency response efforts including: 1) Strengthening the link among epidemiology, lab and environmental health/regulatory components; 2) Improving States' regulatory and surveillance HAF protection programs to include using Incident Command System (ICS)/National Incident Management System (NIMS) principles and a Unified Command structure to conduct integrated responses to all-hazards HAF emergencies, rapidly identifying and removing tainted food from commerce, and conducting root cause investigations to inform future prevention efforts; and 3) Addressing supporting components, such as training, data sharing, data analysis, communications, continuous process improvement, and development of best practices and other resources to support national response capacity/capability development. Awards range from $360,000 to $1,440,000.
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Deadline not published
The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity objectives. Areas of interest include: Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs. Awards range from $250,000 to $1,000,000.
OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Food and Drug Administration · Deadline not published
The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on potential risks from skin lightening products containing hydroquinone and/or mercury. Applicants will research and propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from over-the-counter (OTC) skin lightening products. Awards range from $250,000 to $250,000.
Long Range Broad Agency Announcement (BAA) for NSWC Crane
NSWC CRANE - N00164 · Deadline not published
This announcement seeks revolutionary research ideas, and technology demonstrators that offer potential for advancement and improvement of NSWC Crane’s primary mission areas. NSWC Crane is a field activity of the Naval Sea Systems Command. NSWC Crane supports a wide range of government agencies in the interest of national security. NSWC Crane may publish BAAs and other solicitations in response to specific needs. This BAA is issued to seek innovative solutions and ideas for topics not covered via other means. It is strongly encouraged that potential proposers review existing NSWC Crane solicitations to avoid duplication of effort and to contact the identified points of contact for each BAA topic to discuss specific details of the needs. The mission of NSWC Crane is to provide research, development, test and evaluation, acquisition engineering, in-service engineering and technical support in its assigned technical capabilities for the United States Navy, Department of Defense components and agencies, and other federal agencies and components engaged in national security. NSWC Crane also works to apply component and system-level product and industrial engineering to surface sensors,
Established Program to Stimulate Competitive Research (EPSCoR): Workshop Opportunities
U.S. National Science Foundation · Deadline not published
The Established Program to Stimulate Competitive Research (EPSCoR) is designed to fulfill the mandate of the National Science Foundation (NSF) to promote scientific progress nationwide. NSF EPSCoR facilitates the establishment of partnerships among academic institutions, government, industry, and non-profit sectors that are designed to promote sustainable improvements in an EPSCoR-eligible jurisdiction’s research infrastructure, Research and Development (R&D) capacity, and R&D competitiveness. Eligibility to participate in NSF EPSCoR funding opportunities, including the EPSCoR Workshop Opportunities program, is described on the EPSCoR website (see criteria for eligibility link ). EPSCoR welcomes proposals for workshops only from institutions within EPSCoR-eligible jurisdictions (i.e. states, territories, commonwealths). These workshops must focus on innovative ways to address multi-jurisdictional efforts on themes of regional or national importance with relevance to the goals and mission of NSF and EPSCoR . Awards up to $200,000.
Plant Genome Research Program
U.S. National Science Foundation · Deadline not published
The Plant Genome Research Program (PGRP) supports genome-scale research that addresses challenging questions of biological, societal and economic importance. PGRP encourages the development of innovative tools, technologies, and resources that empower a broad plant research community to answer scientific questions on a genome-wide scale. Emphasis is placed on the scale and depth of the question being addressed and the creativity of the approach. Data produced by plant genomics should be usable, accessible, integrated across scales, and of high impact across biology. Training, broadening participation, and career development are essential to scientific progress and should be integrated in all PGRP-funded projects. Two funding tracks are currently available: RESEARCH-PGR TRACK: Genome-scale plant research to address fundamental questions in biology, including processes of economic and/or societal importance. TRTech-PGR TRACK: Tools, resources, and technology breakthroughs that further enable functional plant genomics.
Cyberinfrastructure for Public Access and Open Science
U.S. National Science Foundation · Deadline not published
The Cyberinfrastructure for Public Access and Open Science (CI PAOS) program within the Office of Advanced Cyberinfrastructure (OAC) aims to catalyze new and transformative socio-technical partnerships supporting research data infrastructure ecosystems across d omains through early-stage collaborative activities between cyberinfrastructure researchers, scie ntists , research computing experts, data management experts , research labs , university libraries , and other communities of practice. The CI PAOS program supports the NSF Public Access Initiative by encouraging innovation across the CI ecosystem t o address accessibility, discoverability, reliability, reproducibility, sustainability, and utility of data products in alignment with NSF and national goals for public access and open science [ See: NSF Public Access Initiative , Office of Science and Technology Policy Memorandum on Ensuring Free, Immediate, and equitable Access to Federally funded Research , and Desirable Characteristics of Data Repositories for Federally Funded Research ] . CI PAOS builds on previous investments including those through Dear Colleague Letters NSF 19-069 , NSF 20 -068 , NSF 23-018 , and the FAIROS Awards range from $50,000 to $600,000.
Health Equity Data Access Program (HEDAP)
Center for Medicare and Medicaid Services · Deadline not published
The Health Equity Data Access program (HEDAP) provides funding for six (6) “seats” in the CMS Virtual Research Data Center (VRDC). The VRDC assists researchers in gaining access to CMS restricted data for minority health research. Seats, in this context are defined as an individual user with VRDC access. These researchers will conduct health services research on health care topics such as physical health, oral health, behavioral health, population health, and social determinants of health focusing on, but not limited to, racial and ethnic minority groups; people with disabilities; members of the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) community; individuals with limited English proficiency; individuals residing in rural areas; and individuals (including children, youth, and families) adversely affected by persistent poverty or inequality. The HEDAP supports specific applied research projects that relate to creative and innovative methods utilizing CMS data to identify, document, assess, and evaluate health disparities among Medicare and Medicaid and CHIP enrollees. The project should enhance the capacity of the researcher to understand and utilize CMS data in future Awards up to $90,000.
Animal Food Regulatory Program Alliance
Food and Drug Administration · Deadline not published
The goal of FDA/ORA's Cooperative Agreement Program is to facilitate long-term improvements to the national food safety system by strengthening interagency collaboration, improving States' regulatory and surveillance protection programs for manufactured foods, conducting research, and promotion of the Animal Food Regulatory Program Standards (AFRPS). Objectives include: 1. Support the efforts of federal and state government agencies to build a national integrated animal food safety system; 2. Establish systems for sharing, promotion, and collaboration of best practices, guidance documents, sampling plans, procedures, memorandums of understanding, and other tools to facilitate and encourage mutual reliance between federal and state animal food regulatory programs and public health agencies; 3. Identify, develop, deliver promote, and/or assist with attendance of animal food safety training programs to support implementation of the AFRPS, as well as training and stakeholder support for provisions of FSMA; and 4. Support the advancement of the AFRPS and future revisions of the AFRPS as part of a system of continuous improvement to ensure the standards are modernized and support the nee Awards range from $600,000 to $600,000.
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
Food and Drug Administration · Deadline not published
The purpose of this Notice of Funding Opportunity (NOFO) is to advance efforts for a nationally integrated animal food safety system providing State animal food regulatory programs the ability to achieve and maintain full implementation of the Animal Feed Regulatory Program Standards (AFRPS), and to fund optional projects for State animal food regulatory programs to develop and standardize processes, procedures, systems, and other methods to integrate federal and state animal food regulatory work resulting in mutual reliance. Specific outcomes may include, but are not limited to: • State animal food regulatory programs will achieve and maintain implementation of the AFRPS, which is recognized as a critical element to creating a national, fully integrated food safety system. • Operational use of standardized animal food regulatory systems developed by state programs to compel federal reliance on state regulatory work and resources and reciprocal state reliance on federal work and resources, resulting in mutual reliance. Outputs, Objectives, and Outcomes for this NOFO are currently under development and subject to change before the submission of the NOFO for clearance. Awards range from $10,600,000 to $10,600,000.
Center for Research on Complex Generics (U18) Clinical Trials Optional
Food and Drug Administration · Deadline not published
The Food and Drug Administration (FDA) seeks to fund a Center for Research on Complex Generics under the terms and conditions of a cooperative agreement. The Center for Research on Complex Generics will support the FDA's efforts to enhance collaborations with the generic drug industry relating to generic drug research, to further the FDA's mission of increasing patient access to high quality, safe, and effective generic drugs. The goals of a Center for Research on Complex Generics include: 1) Facilitating engagement with generic industry representatives to help identify scientific challenges for generic product development or assessment, and helping to inform FDA about priority areas for research to address these challenges by supporting engagement and coordination between the FDA and key generic industry industry associations, companies, and representatives. 2) Providing a forum for experts from FDA, academia, the generic drug industry, and elsewhere to collaborate on research related to generic products. 3) Coordinating and conducting research projects pertaining to generic products, particularly complex generics. 4) Hosting scientific workshops, providing training, and supportin Awards range from $1,500,000 to $1,500,000.
Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center
Food and Drug Administration · Deadline not published
The Office of Partnerships (OP) would like to develop a Notice of Funding Opportunity (NOFO) to award a $1.5M cooperative agreement to a non-profit entity to serve as the Integrated Food Safety System (IFSS) Regulatory and Laboratory Training System (RLTS) National Coordination Center (NCC). The NCC will provide day-to-day oversight to the RLTS. The RLTS will leverage the expertise and resources of all IFSS partners to improve access to high quality human and animal food regulatory and laboratory training and other learning resources. • Oversee the day-to-day administration of the RLTS and implementation of the IFSS RLTS Strategic Plan and Implementation Plan. • Oversee communications related to the IFSS RLTS. • Update the strategic and implementation plans working with stakeholders. • Complete standing up the governance structure and processes for the RLTS. • Establish a process for stakeholders to recommend changes to training content, design, delivery, and alignment determination standards and policies. • Recommend changes to course content, design, delivery, and alignment determination standards and policies to the IFSS RLTS SC for approval. • Determine alignment of training co Awards range from $1,500,000 to $1,500,000.
Studies Addressing Rare Neurodegenerative Diseases including ALS
Food and Drug Administration · Deadline not published
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Retail Food Safety Regulatory Association Collaboration CAP
Food and Drug Administration · Deadline not published
The proposed cooperative agreement is a renewal of the existing CAP supporting key stakeholders in retail food safety to coordinate and advance retail food protection in the United States. The intended outcome of this NOFO is to collaboratively advance retail food safety initiatives to reduce food-borne illness. This cooperative agreement is intended to advance practices in retail food protection, conduct research related to such practices and identify opportunities for collaboration to reduce the occurrence of food-borne illness risk factors. Awards range from $4,000,000 to $4,000,000.
Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
Food and Drug Administration · Deadline not published
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of pre-clinical studies of anesthetic neurotoxicity. Multiple awards may be considered. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders. Awards range from $2,000,000 to $2,000,000.
Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines
Food and Drug Administration · Deadline not published
To support dissemination of clinical practice guidelines, particularly those whose development was previously supported by FDA cooperative agreements. Applicants must propose a comprehensive plan to develop, evaluate, and distribute materials to facilitate dissemination, with a focus on equity. Awards range from $1,000,000 to $1,000,000.
Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
Food and Drug Administration · Deadline not published
The purpose of this notice of funding opportunity (NOFO) is to fund innovative research that will strengthen and advance minority health and health equity objectives. Areas of interest include: Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs. Awards range from $1,000,000 to $1,000,000.
REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
Food and Drug Administration · Deadline not published
This purpose of this notice of funding opportunity (NOFO) is for FDA Office of Minority Health and Health Equity's (OMHHE) Health Equity Innovation Award: Racial & Ethnic Minority Acceleration Consortium for Health Equity (REACH). The consortium will consist of multiple cooperative agreement (U01) recipients that will strengthen and advance minority health and health equity focused research, outreach, and communications as well as support training and mentoring of diverse students, fellows, and/or researchers. Awards range from $3,000,000 to $3,000,000.
Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed
Food and Drug Administration · Deadline not published
The purpose of the funding opportunity is to expand and advance FDA's Office of Minority Health and Health Equity (OMHHE) work with stakeholders and partners for education, outreach, and public awareness activities on the use of and potential risks from skin lightening products (e.g., hydroquinone). Applicants will propose innovative and community-based strategies and activities that have the potential to strengthen the science base for education and public health awareness on the use of and potential risks from skin lightening products. Awards range from $250,000 to $250,000.
Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
Food and Drug Administration · Deadline not published
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development. Awards range from $650,000 to $900,000.